The ongoing turbulence in global trade policy, particularly the re-escalation of tariffs on medical supplies from China and other countries, is weighing heavily on US healthcare operations. Sweeping US trade policy shifts this year are sparking great concern, but while 2025 has seen unprecedented tariff escalations and supply chain volatility, the concern began mounting as early as May 2024, when the Biden administration reignited trade tensions by expanding tariffs on Chinese medical imports.
Robotic surgery has moved from cutting-edge to commonplace. The question…
Office-based surgery (OBS) is one of the fastest-growing care settings…
Stress and burnout are more than workforce concerns; they are…